$ Value
$7.8M
Shares
855,047
Price
$9
Filed
Oct 8
Insider
Name
Fairmount Funds Management LLC
Title
—
CIK
0001802528
Roles
Transaction Details
Transaction Date
2025-10-06
Code
A
Table
Derivative
Ownership
Indirect
Equity Swap
No
Shares After
855,047
Footnotes
The shares of Common Stock and Pre-Funded Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended. | Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. and Fairmount Healthcare Co-Invest IV L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. | The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of outstanding shares of common stock of the Issuer immediately after giving effect to such exercise.
Filing Info
Fairmount Funds Management LLC's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | COGT | C | — |
| 2026-03-31 | COGT | ▼ | $242.6M |
| 2026-03-31 | COGT | C | $0 |
| 2026-03-31 | ZBIO | ▲ | $3.0M |
| 2026-03-23 | DMRA | A | $0 |
| 2026-01-22 | APGE | ▼ | $133.5M |
| 2026-01-22 | COGT | ▼ | $127.4M |
| 2025-12-04 | CBIO | ▲ | $18.2M |
| 2025-12-04 | CBIO | ▲ | $1.8M |
| 2025-10-23 | VRDN | ▲ | $10.0M |
Other Insiders at JBIO (90d)
No other insider activity at this issuer in the last 90 days.